ZenaTech (NASDAQ: ZENA) (FSE: 49Q) (BMV: ZENA), a technology solutions provider specializing in artificial intelligence (“AI”)-powered drones, Drone as a Service (“DaaS”), enterprise software and quantum computing, announced that its ZenaDrone subsidiary has signed a memorandum of understanding (“MOU”) with Rattler Medical Inc. to develop and manufacture a drone-based battlefield blood delivery system. The proposed system will combine ZenaDrone’s cargo drone capabilities with Rattler Medical’s temperature-controlled blood transport containers to deliver blood to military medical personnel more quickly while reducing reliance on ground transportation in combat environments.
Under the agreement, the companies plan to develop and test a flying prototype within two to three months, evaluating delivery methods that include aerial release and landing-based deployment. ZenaDrone is targeting a demonstration at a U.S. military facility in summer 2027. The initiative expands ZenaTech’s defense portfolio into battlefield medical logistics, with the companies seeking to improve blood resupply capabilities and reduce risks associated with transporting medical supplies through contested areas.
To view the full press release, visit https://nnw.fm/9Mjz5
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer